Table 4.
Definitive Antibiotic Therapy Switch in Propensity-Matched EIE Patients Initially Treated With Ampicillin-Ceftriaxone or Ampicillin-Gentamicin
| AC (n = 49)a | AG (n = 49)a | P Value | |
|---|---|---|---|
| No. of patients with therapy switch (%) | 5 (10) | 24 (49) | <.0001 |
| Duration of AC or AG therapy before switch,b d | 13 (3–19) | 11 (7–24) | .55 |
| Reason for switch,c No. | |||
| Adverse event | 4 | 12 | |
| Treatment failure | 0 | 1 | |
| Other | 1 | 11 | |
| Unknown | 0 | 3 |
Abbreviations: AC, ampicillin-ceftriaxone; AG, ampicillin-gentamicin; EIE, enterococcal infective endocarditis.
aMissing data for 7 patients in each matched group.
bValues are median (interquartile range).
cSeveral patients had multiple documented reasons for switching definitive antibiotic therapy.